Janeen Noel Doyle

Insider Reports History

Location
San Diego, CA
Signature
/s/ James Pennington, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Janeen Noel Doyle:

Company Role Class Num Shares Value Price $ Report Date Ownership
Janux Therapeutics, Inc. Chief Corp. & Bus. Dev. Ofcr Common Stock 80,000 $1,268,800 $15.86 02 Jan 2026 Direct
Janux Therapeutics, Inc. Chief Corp. & Bus. Dev. Ofcr Stock option (right to buy) 126,000 02 Jan 2026 Direct

Insider Reports Filed by Janeen Noel Doyle

Symbol Company Period Transactions Value $ Form Type Role Filing Time
JANX Janux Therapeutics, Inc. 02 Jan 2026 2 $0 4 Chief Corp. & Bus. Dev. Ofcr 02 Jan 2026, 21:00
JANX Janux Therapeutics, Inc. 02 Jun 2025 2 $0 4 Chief Corp. & Bus. Dev. Ofcr 04 Jun 2025, 20:00
JANX Janux Therapeutics, Inc. 14 May 2025 0 $0 3 Chief Corp. & Bus. Dev. Ofcr 23 May 2025, 20:02